Developing targeted antimalarial drug leads from host defence peptide-drug conjugates

Researchers

Grant status

Active

Grant start date

01/01/2020

Grant funding

  • 2020: $385,104 from National Health and Medical Research Council (NHMRC)
  • 2021: $372,954 from National Health and Medical Research Council (NHMRC)
  • 2022: $304,979 from National Health and Medical Research Council (NHMRC)

Updated:  06 May 2021 / Responsible Officer:  Director (Research Services Division) / Page Contact:  Researchers